FSCN1通过抑制TRIM38介导的IGF2BP1泛素化促进类风湿关节炎进展
该研究探讨FSCN1在类风湿关节炎成纤维样滑膜细胞(FLS)表型活化中的作用及机制。FSCN1在RA滑膜中显著升高,通过空间隔离TRIM38抑制IGF2BP1泛素化,维持PI3K-AKT/NF-κB信号,促进FLS侵袭和炎症。FSCN1抑制剂可减轻小鼠关节炎病理。
要点
- FSCN1在RA滑膜中显著升高并主要定位于PDPN阳性FLS。
- FSCN1通过抑制TRIM38介导的IGF2BP1泛素化维持PI3K-AKT/NF-κB信号。
- FSCN1抑制剂丙咪嗪和NP-G2-044可减轻小鼠关节炎病理。
核心结论
- FSCN1通过抑制TRIM38介导的IGF2BP1泛素化促进FLS侵袭性表型,药理学抑制FSCN1可减轻滑膜炎症和关节破坏,是RA潜在治疗策略。
研究设计与样本
- 研究分析健康对照(n=6)、RA患者(n=6)和骨关节炎患者(n=6)滑膜及对照(n=6)和关节炎小鼠(n=6)滑膜中FSCN1表达。
- 采用转录组分析、RNA免疫沉淀测序和质谱分析确定机制。
- 使用FLS特异性FSCN1敲除、FSCN1关节内过表达小鼠和FSCN1抑制剂在实验性关节炎中表征作用(n=5-8)。
主要发现
- FSCN1在RA滑膜中显著增加并主要定位于PDPN阳性FLS(P < 0.001)。
- FSCN1过表达增强F-actin重塑、FLS迁移、侵袭、增殖和炎症活化,并加重关节炎小鼠模型滑膜炎和软骨损伤(P < 0.0026)。
- FLS特异性FSCN1敲除减轻关节炎小鼠膝关节肿胀、疼痛相关行为、滑膜炎症和OARSI评分(P < 0.0196)。
- FSCN1抑制剂丙咪嗪和NP-G2-044抑制FLS活化并减轻小鼠关节炎病理(P < 0.001)。
临床怎么用
- FSCN1抑制剂(丙咪嗪和NP-G2-044)在 mice 中抑制FLS活化并减轻关节炎病理,提示其作为RA治疗策略的潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Fibroblast-like synoviocytes (FLS) in rheumatoid arthritis (RA) synovium acquire a unique aggressive phenotype and produce cytokines that perpetuate inflammation and proteases that contribute to cartilage destruction. Actin-bundling protein Fascin-1 (FSCN1) is involved in FLS migration and invasion, but its role and mechanism in FLS phenotypic activation remain unclear. METHODS: FSCN1 expression was analyzed in the synovium from healthy controls (n = 6), patients with RA (n = 6), and patients with osteoarthritis (n = 6) with written informed consent obtained before sample collection, as well as synovium from control (n = 6) and arthritic mice (n = 6). Transcriptome profiling, RNA immunoprecipitation sequencing, and mass spectrometry analysis were performed to determine the underlying mechanism. FLS-specific FSCN1 knockout, FSCN1 intra-articular overexpression mice, and FSCN1 inhibitors were used to characterize the role and therapeutic potential of FSCN1 in experimental arthritis (n = 5-8). RESULTS: FSCN1 was significantly increased in RA synovium and predominantly localized to PDPN-positive FLS (P < 0.001). FSCN1 overexpression enhanced F-actin remodeling, FLS migration, invasion, proliferation, and inflammatory activation and exacerbated synovitis and cartilage damage in arthritis mouse models (P < 0.0026). Conversely, FLS-specific FSCN1 ablation reduced knee swelling, pain-related behavior, synovial inflammation, and Osteoarthritis Research Society International scores in arthritis mouse models (P < 0.0196). Mechanistically, FSCN1 promoted F-actin fiber formation, spatially sequestered tripartite motif-containing protein 38 (TRIM38), inhibited TRIM38-mediated IGF2BP1 ubiquitination, and sustained PI3K-AKT/NF-κB signaling. The FSCN1 inhibitors imipramine and NP-G2-044 suppressed FLS activation and alleviated arthritis pathology in mice (P < 0.001). CONCLUSION: Pharmacologic inhibition of FSCN1 restrains synovial inflammation and joint destruction by suppressing the aggressive phenotype change of FLS, representing a promising therapeutic strategy against RA.
引用
- Chen L, Wu J, Zhou T, et al. FSCN1 Promotes Rheumatoid Arthritis Progression via Inhibiting TRIM38-Mediated Ubiquitination of IGF2BP1 in Fibroblast-Like Synoviocytes. Arthritis Rheumatol. 2026. PMID: 42608901. doi:10.1002/art.70300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。